calretinin is an OSE marker; PAX8 marks the secretory cells of FTE; and WT1 is a marker of both OSE and FTE. As previously reported (Davidson and Trope, 2014) , EOC cells were positive for both PAX8 and WT1. Cytokeratin 7 (CK7), an established marker of the female gynecological tract epithelium, was abundant in all primary cell types. the overlap between the phosphorylated proteins identified in this study and in Zhang et al., (Zhang et al., 2016) . (C) Network of proteins belonging to cluster A (see Figure 4A ) based on STRING and visualized in Cytoscape (D) List of the phosphorylated sites up-regulated in EOC and FTE (cluster B in Figure 4A ). CDK7, *: the doubly phosphorylated peptide is reported (see Tables S3 and S4) . have been found in the COSMIC database (ovarian and breast cancers only). This supported the depth of our analysis. Among the highly interconnected groups of proteins we found proteins involved in splicing and translation as up regulated in EOC, whereas sites on signaling proteins were down regulated in EOCs. One-third of all EOC specific sites in cluster C were associated with the GO term spliceosome (Table S4) . Phosphorylation sites on proteins involved in chromosome organization and cell cycle were up-regulated in both FTE and EOC. These findings highlight these important cellular functions as targets of differential phosphorylation between EOC and healthy cells. Table S1 ).
Representative serial images are shown on the left. Scale bar, 100 m. Enlarged sections from the rectangular area are represented on the right of the respective staining. Tissue sections incubated with the secondary antibodies alone showed no staining and are not shown. Arrows indicate the OSE in normal ovary, the FTE in normal fimbriae, and the tumor tissue in EOC. Right panel:
summary table of the IHC signal intensities (arbitrary unit) of each target protein (columns) in each tissue (rows). Active CDK7 was strongly represented in the nuclei of EOC and FTE, whereas it was heterogeneous in OSE and detected in groups of cells. (C) Recurrent EOC retains the expression of active and total CDK7. Two independent samples of recurrent high-grade serous ovarian carcinoma from patients who had been previously treated with primary debulking surgery followed by carboplatin/paclitaxel chemotherapy (Table S1) were stained for active (p-CDK7) or total (CDK7).
Representative images are shown. Control staining was performed omitting the primary antibodies (no primary Ab). Scale bar, 100 m. Of the 5561 identified proteins we filtered proteins identified with less than two peptides and with poor sequence coverage (less than 5%) before further analysis (4457 proteins). MUC16/CA125 and PRSS8 are identified by an asterisk. Proteins in red were differentially expressed in the three tissues based on intensity. The log10 intensity is reported for all the samples as well as the normalized mean. We also reported the significant p value after the analysis with the LIMMA Bioconductor package in R and the cluster.
Table S3. Related to Figures 1 and 3-5. List of the identified phosphorylated sites in patient-
derived cells. Sequence window, phosphorylated amino acid residue, the log10 intensity of all phosphorylated sites with localization probabilities higher than 0.75 (class I), the normalized mean, the GO terms, the significant p value after the analysis with the LIMMA Bioconductor package in R, the significance in the PCA analysis or after the comparison with Lawrence et al., (Lawrence et al., 2014) are reported for all the samples. CDK7 is shown in red. For the 792 differentially expressed phosphorylated sites in patient-derived cells, the p-values < 0.05 and p-values >=0.05 are color-coded in shades of red and of blue, respectively. The phosphorylated sites whose proteins have been also identified in the proteome dataset are marked with a YES. If the p-value remained significant also after the normalization of the intensity of the site over the intensity of its protein they were marked with a "+" (175 out of 665 sites). The peptide found in proteins with splicing variants were marked with a "+". CDK7 and POLR2A are shown in red. CDK7: the doubly phosphorylated peptide is reported. the significance in the PCA analysis or after comparison with the proteome analysis, the kinase motif, the function according to (Papasaikas et al., 2015) are reported. POLR2A is shown in red. Sequence window, phosphorylated amino acid residue, the log10 intensity of all phosphorylated sites with localization probabilities higher than 0.75 (class I), motif analysis, the GO terms, biological functions, the presence in patient-derived cells, the name of the cluster are reported.
POLR2A is shown in red. References for the column "Domains for splicing?": 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Reagents
The following commercial reagents were used: DMSO (Sigma-Aldrich, St. Louise, MO); the EGFR inhibitor AG1478, the PI3K inhibitor LY294002, and the MEK inhibitor U0126 (Cell Signaling
Technology, Danvers, MA); the CDK7 inhibitor THZ1 (ApexBio, Houston, US). fetal bovine serum, 2mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 100 μg/mL gentamycine, 0,5 μg/mL Amphotericin B, 10 μg/mL human transferrin, 1 μg/mL human insulin, 1 μg/mL hydrochortisone, 10mM Hepes, 10μM L-ascorbic acid, 15nM sodium selenite, 0.1 mM ethanolamine, 50ng/mL cholera toxin, 10nM epidermal grow factor EGF, Bovine Pituitary Extract 35 μg/mL, 10nM β-estradiolo, 10nM Triiodothyronine, in a humidified incubator with 5% CO2. All primary cell batches were cultured for a maximum of three passages after tissue digestion in order to preserve the biological features and the heterogeneity of original tissue.
Cell lines
Human ovarian carcinoma cell lines (EOC) OVCAR3, IGROV1, HeyA8, and SKOV3, human epithelial cervix carcinoma HeLa cells, breast adenocarcinoma cells MCF7, lung adenocarcinoma A549 cells were purchased from ATCC. COV362 and COV318 were purchased from Sigma. All cells were tested for mycoplasma with a PCR-based method every third week. Cells were maintained in a humidified incubator with 5% CO2. IGROV-1 cells were cultured in RPMI 1640
(Lonza) supplemented with 10% fetal bovine serum, 2mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin; SKOV3 cells were cultured in McCoy"s 5A (Life Technologies) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 μg/mL streptomycin.
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HeyA8, COV362, and COV318 cells were cultured in DMEM supplemented with 10% fetal bovine serum, 2mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin. OVCAR3 cells were cultured in RPMI 1640 medium supplemented with 20% fetal bovine serum, 10 μg/mL insulin, 100 U/mL penicillin and 100 μg/mL streptomycin. HeLa, A549, and MCF-7 cells were cultured in DMEM (Gibco, Invitrogen), supplemented with 10% fetal bovine serum, 100U/mL penicillin (Invitrogen), 100μg/mL streptomycin (Invitrogen). All experiments were performed at 80%
confluence.
Cell Lysis and Western blots
EOC cell lines were cultured in Petri dishes in complete medium and treated for 4 hours with chemical inhibitors at the indicated concentrations. Control cells were pre-incubated with DMSO alone. After treatment, cell extraction and immunoblotting were performed as described (Francavilla et al., 2013) . Each experiment was repeated three times. The pellet of primary cells not used for Mass Spectrometry analysis was directly used for immunoblotting.
Transfection and RNA interference
OVCAR3 cells were transfected using Lipofectamine (Invitrogen), according to manufacturer"s instructions, and all the assays were performed 36 hours after transfection. Double-strand, validated Stealth siRNA oligonucleotides targeting human CDK7 (sequences: 5"-UUAAGGUUUCCACUGGACAGUUUGG -3"; 5"-UCACACAUCAAAGCCUACAUGUUGA-3)
were purchased from Invitrogen. Cells were transfected either with two sequences in order to test off-target effects. A Negative Control Med GC siRNA duplex was used as a negative control (Invitrogen, Cat. Num. 12935300). Silencing of gene expression was monitored by immunoblotting of cell lysates with antibodies against CDK7.
Cell Proliferation Assay
21
EOC cell lines were seeded in quadruplicate on 24-well plates at 2x10 4 cells/well and treated for three days with chemical inhibitors replenished every 24 hours. Viable cells were counted using the Trypan blue exclusion method and the ratio to unstimulated cells at time 0 was determined for each time point, as previously described (Francavilla et al., 2013) . Values represent the mean ± s.e.m.
from four independent experiments.
Immunofluorescence
Primary cells (see Table S1 ) were grown on glass coverslips coated with collagen I from calf skin (Sigma), and then fixed with 4% PFA for 10 min at room temperature. When needed, cells were permeabilized for 3 minutes at 4°C with 0.5% Triton X-100 in PBS. After treatment for 30 min at room temperature with blocking solution (1% donkey serum and 0.2% BSA in PBS, 0.05% Tween20) primary antibodies diluted in blocking solution were added for 2 hours at room temperature. Anti-CD31, anti-CD45 and anti-WT1 primary antibodies were detected with Cy3-conjugated donkey anti-mouse antibody; anti-CK5, anti-calretinin, anti-PAX8 and anti-CK7 were detected with Cy3-conjugated donkey anti-rabbit antibody; anti-FAP with an Alexa Fluor 488-conjugated anti-rat. All secondary antibodies were incubated for 1 hour at room temperature in blocking solution, and nuclei were counterstained with DAPI. Coverslips were then mounted with Mowiol. Images were acquired with an OLYMPUS BX63 microscopy, 20x objective, and processed by the software Fiji. The EVOS fl Digital Inverted Fluorescence Microscope was used for the bright-field images of primary cells shown in Supplementary Fig 1a. The experiments were repeated at least twice and representative images are shown.
Immunohistochemistry (IHC) staining
The immunohistochemical analysis of CDK7 and phospho-CDK7 expression was carried out on 4 normal ovaries, 4 normal FTE, and 4 EOC (Table S1 ). Immunostaining was performed on 3-μm sections from formalix-fixed, paraffin-embedded tissue samples. Tissue samples were
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For the CDK7 staining, endogenous peroxidases were inactivated by 0.03% H2O2 in methanol for 20 min at room temperature. Primary antibodies were added for 2 hours at room temperature or, for anti-CDK7, over-night at 4°C. Dako EnVision+ System-HRP Labelled Polymer was used for detection, in combination with Dako chromogen substrate (Liquid DAB+ Substrate Chromogen System). Sections were counterstained with hematoxilin. Pictures of stained sections were acquired with the scanner Aperio ScanScope XT, 20x objective. The antigen expression in whole tissue sections was analyzed and scored by a trained pathologist (GB).
Tissue Microarray (TMA)
Tissue microarray (TMA) analysis was carried out as previously described (Zecchini et al., 2008) .
Clinicopathological and follow-up data of ovarian cancer patients operated at the European Institute of Oncology (Milano, Italy) from 1995 to 2004 were used to select the cases that were included in the study. Inclusion criteria were: a) first surgery at the European Institute of Oncology; b) no neoadjuvant treatment; c) diagnosis of serous ovarian carcinoma. We selected 15 OSE, 18
Fimbriae, 84 serous adenocarcinomas and 34 metastases. TMA was constructed by using the tissue arrayer MiniCore 3 (Alphelys, Plaisir, France). IHC on TMA was carried out with the anti-PHGDH and anti-KCTD12 antibodies. TMAs were deparaffinized, rehydrated, and pretreated in Tris-EDTA buffer pH 9 at 95°C for 50 min for antigen retrieval, followed by the incubation with the primary antibodies at room temperature for 2 hours. As detection system, the Dako EnVision+ System-HRP 
Sample preparation for Mass-Spectrometry

Primary Cells
We analyzed five FTE, four OSE and four EOC from individual patients (see Table S1 ). Three of the four EOC were separated into two distinct samples and analyzed as technical replicates (see Figure S2 ). The pellet of primary cells was dissolved in denaturation buffer (6 M urea, 2 M thiourea in 10 mM HEPES pH 8) and protein concentration was determined using BioRad Bradford reagent (Bio-Rad, Hercules, CA). We obtained about 700 g of proteins from each sample. Cysteines were reduced with 1 mM dithiothreitol (DTT) and alkylated with 5.5 mM chloroacetamide (CAA).
Proteins were digested with endoproteinase Lys-C (Wako, Osaka, Japan) and sequencing grade modified trypsin (modified sequencing grade, Sigma) after four-fold dilution in deionized water.
Protease activity was quenched by addition of trifluoroacetic acid (TFA) to a final concentration of 1%. Precipitates were removed by centrifugation for 10 min at 3,000 g. Peptides were purified using reversed-phase Sep-Pak C18 cartridges (Waters, Milford, MA) and eluted with 50% acetonitrile. A small amount of the eluted peptides (1%) was taken for proteome analysis: after evaporation in a speed vacuum, 40 μL of 0.1% TFA, 5% ACN were added followed by MS analysis. The remaining peptides were used for the analysis of phosphoproteome as previously described (Jersie-Christensen et al., 2016) . Briefly, 6 mL of 12% TFA in ACN was added to the eluted peptides and subsequently enriched with TiO 2 beads (5 μm, GL Sciences Inc., Tokyo, Japan).
The beads were suspended in 20 mg/mL 2,5-dihydroxybenzoic acid (DHB), 80% ACN, and 6%
TFA and the samples were incubated in a sample to bead ratio of 1:2 (w/w) in batch mode for 15 min with rotation. After 5 min centrifugation the supernatant were collected and incubated a second
To be considered as a Resource Article in Cell Reports 24 time with a two-fold dilution of the previous bead suspension. The beads were washed with 10% ACN, 6% TFA followed by 40% ACN, 6% TFA and collected on C 8 STAGE-tips and finally washed by 80% ACN, 6% TFA. Elution of phosphorylated peptides was done with 20ul 5%
NH 3 followed by 20 μL 10% NH 3 in 25% ACN, which were evaporated to a final volume of 5 μL in a sped vacuum. The concentrated phosphorylated peptides were acidified with addition of 20 μL 0.1% TFA, 5% ACN and loaded on C 18 STAGE-tips. Peptides were eluted from STAGE-tips with 20 μL of 40% ACN followed by 10 μL 60% ACN and reduced to 5 μL by SpeedVac and added of 5 μL 0.1% TFA, 5% ACN.
EOC cell line OVCAR3
We analyzed triplicates of label-free lysates from OVCAR3 treated with DMSO as control, with 300 nM THZ1, or with 20 nM U0126. We followed the same procedure described above to investigate both the proteome (not shown) and the phosphoproteome (Table S6 ) of OVCAR3. We analyzed 10 mg proteins from each sample.
Mass-Spectrometry analysis
Primary Cells
Peptide mixtures were analyzed using an EASY-nLC system (Proxeon, Odense, Denmark)
connected to a Q Exactive mass spectrometer (Thermo Fisher Scientific, Bremem, Germany) through a nanoelectrospray ion source. Peptides were separated in a 15 cm analytical column (75 µm inner-diameter) in-house packed with 1.9 µm reversed-phase C 18 beads (Reprosil-Pur AQ, Dr.
Maisch, Ammerbuch, Germany) with a 90 min gradient from 6% to 80% ACN in 0.5% acetic acid at a flow rate of 250 nl/min. Standard mass spectrometric parameters were as follows: spray voltage, 2 kV; no sheat and auxiliary gas flow, heated capillary temperature, 275°C; S-lens RF level of 50%. The Q-Exactive was operated in data-dependent acquisition mode using the "sensitive scanning method", as described (Kelstrup et al., 2012) . Full-scan MS spectra (m/z 300-1,750,
To be considered as a Resource Article in Cell Reports 25 resolution 70,000 at m/z 200) were detected in the Orbitrap analyzer after accumulation of ions at 1e6 target value based on predictive AGC from the previous scan. For every full-scan the 10 most intense ions were isolated and fragmented (collision energy: 25%) by higher-energy collisional dissociation (HCD) with a fixed injection/fill time of 120 ms and 35,000 resolution. Finally, the dynamic exclusion was set to 30 seconds.
OVCAR3 Phosphorylated peptides-enriched samples were separated on an in-house packed 50 cm capillary column with 1.9 μm Reprosil-Pur C18 beads using an EASY-nLC 1000 system (Thermo Scientific, Odense, Denmark). The column temperature was maintained at 50°C using an integrated column oven (PRSO-V1, Sonation GmbH, Biberach, Germany). The flow rate of the gradient was 250 nl/min and started at 5% buffer B (80% ACN, 0.1% Formic Acid) going to 25% buffer B in 220 min followed by a 30 min step going to 60% buffer B and continuing for a 5 min wash and returning to 5% in 5 min and continuing for re-equilibration for 5 min. The Q-Exactive HF instrument (Thermo Scientific, Bremen, Germany) was run in a data dependent top 10 mode with the following settings. Spray voltage was set to 2 kV, S-lens RF level at 50, and heated capillary at 275 °C. Full scan resolutions were set to and 120 000 at m/z 200 and scan target was 3 × 10 6 with a maximum fill time of 20 ms. Mass range was set to 300-1750 and dynamic exclusion to 20 s.
Target value for fragment scans was set at 2 × 10 5 with a resolution of 60 000 and a maximum fill time of 108 ms and underfill ratio was 4%. Normalized collision energy was set at 28. For proteome samples the mass spectrometer was run with a top 12 method with a resolution for fragment scans of 30 000 and a maximum fill time of 45 ms.
Raw files analysis
Raw data were analyzed by the MaxQuant software suite (Cox and Mann, 2008) , version 1.4.1.4
using the integrated Andromeda search engine (Cox et al., 2011) . Proteins were identified by searching the HCD-MS/MS peak lists against a target/decoy version of the human Uniprot database that consisted of the complete proteome sets and isoforms (v 3.37) supplemented with commonly observed contaminants such as porcine trypsin and bovine serum proteins. Tandem mass spectra were initially matched with a mass tolerance of 7 ppm on precursor masses and 0.02 Da or 20 ppm for fragment ions. Cysteine carbamidomethylation was searched as a fixed modification. Protein Nacetylation, N-pyro-glutamine, oxidized methionine, and phosphorylation of serine, threonine, and tyrosine were searched as variable modifications. Protein N-acetylation, oxidized methionine and deamidation of asparagine and glutamine were searched as variable modifications for the proteome experiments. Label-free parameters were used as described (Cox et al., 2014) . False discovery rate was set to 0.01 for peptides, proteins and modification sites. Minimal peptide length was six amino acids. Site localization probabilities were calculated by MaxQuant using the PTM scoring algorithm (Olsen et al., 2006) . The dataset were filtered by posterior error probability to achieve a false discovery rate below 1% for peptides, proteins and modification sites. Only peptides with Andromeda score >40 were included.
Data analysis
The samples were grouped in three categories representing EOC, FTE and OSE. For the analysis of phosphorylated peptides, only peptides with site localization probability of at least 0.75 (class I, shown in Tables S3 and S8 ) (Olsen et al., 2006) were included in the bioinformatics analyses. Both for the proteome and for the phosphoproteome analysis of primary cells we considered 8 out of 13 values that were log transformed and normalized using the function "normalizeQuantiles" included in the LIMMA package of Bioconductor in R. The LIMMA package from Bioconductor ( (Wettenhall and Smyth, 2004) add http://www.ncbi.nlm.nih.gov/pubmed/16646809) was chosen to detect significant changes in abundance between the three groups because it accounts for different variability between samples and also between proteins. All values were centered to the mean. The samples were analyzed as pairs and we considered changes in abundance significant if observed in
To be considered as a Resource Article in Cell Reports 27 at least two of the three pair of samples based on a false discovery rate of < 0.05. We represented the modified peptides/proteins whose value differed compared to the mean of all samples. For the analysis of OVCAR3 phosphoproteome we calculated the difference of the phosphorylated peptide intensity between treated and untreated controls and considered significant a difference of more than 2 or less than minus 2 after log transformation of the data.
Hierarchical and unsupervised clustering and the analysis of kinases motif were performed using the Perseus software (Tyanova et al., 2016) . For 3D-PCA, performed using the R package "pca. All the protein interaction networks were obtained using the STRING v9.1 protein interaction database (Franceschini et al., 2013) . To ensure high confidence, interactions derived from the Experiments and Databases evidence channels were retrieved and a confidence score above 0.8 was required. To identify hyperconnected proteins in Figure S 7 the DAPPLE (Disease Association Protein-Protein Link Evaluator) tool was used (Rossin et al., 2011) . The DAPPLE algorithm builds interaction networks among the proteins of interest and computes statistical significance of their connectivity. Data visualization was performed using the software Cytoscape (version 3.1 or 3.2.0).
Genes reported to be significantly mutated in cancer were retrieved from (Lawrence et al., 2014) .
The analysis of splicing components was done as previously reported (Papasaikas et al., 2015) . The relation of genes to other diseases was based on the database DISEASES (Pletscher-Frankild et al.,
2015) ( Figure S5 ). Genes mutated in cancer were taken from the COSMIC database and we
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For the analysis of the proteins with splicing variants, the amino acid sequence fasta file of human Uniprot database that consisted of the complete proteome sets and isoforms (v 3.37) was used as a reference database and the enzymatic digestion of all proteins with alternative variants was calculated (see Perl Script in Table S7 ).
The produced peptides found to be protein specific were further annotated as variant specific or variant non-specific. Next a Fisher"s exact test was performed to determine statistical significance between peptides belonging to proteins with splicing variants whose phosphorylated sites were regulated in EOC compared to healthy tissues.
Statistics
All the experiments have been performed in at least triplicates. All the MS experiments have been performed with n> 3 to ensure adequate power to the analysis. The data were normalized before further analysis. P value was calculated by Student´s two tailed t-test, Wilcoxon test or Fisher´s exact test, as indicated. A statistically significant difference was concluded when p value < 0.05 or < 0.001 as reported in the figure legends. 
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